{
    "SPADE_N_13993": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13993",
            "Peptide Name": "Hill_BB_C10074 (attacin, antimicrobial protein; natural AMPs; insects, arthropods, invertebrates, animals; UCLL1, BBMm)",
            "Source": "the Black Solider Fly,Hermetia illucens",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "LPQNNIADDDFQEVQRYSSRIIDPGSQFLIRGEDLDDIFEPREEEGLPEDVIRARRSPQDGRRGSASVTVNNESRRGTDVRADLNARLWEGNNRRSSLDANAYYQRHFGGPMGTGRPDAGVGLNFRHRF",
            "Sequence Length": 129,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 14659.75,
            "PI": 5.41,
            "Hydrophobicity": -1.06,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "ahmy L, Ali YM, Seilly D, McCoy R, Owens RM, Pipan M, Christie G, Grant AJ. 2023",
                    "Reference": "BMC Microbiol. 2023 Dec 1;23(1):378. doi: 10.1186/s12866-023-03131-1.PubMed",
                    "Title": "An attacin antimicrobial peptide, Hill_BB_C10074, from Hermetia illucens with anti-Pseudomonas aeruginosa activity"
                }
            ],
            "Frequent Amino Acids": "RDG",
            "Absent Amino Acids": "CKOU",
            "Basic Residues": 21,
            "Acidic Residues": 22,
            "Hydrophobic Residues": 46,
            "Polar Residues": 65,
            "Positive Residues": 21,
            "Negative Residues": 22,
            "Net Charge": -1,
            "Comments": "Discovery: first identified throught bioinformatic study in silico (Moretta et al., 2020). Antimicrobial activity was demonstrated using a His-tagged recombinat form in 2023 (see ref).Sequence analysis: APD analysis reveals that this sequence is poorly similar (37.5%) toLugensin B. R: 15%; G=D: 10%. GRAVY: -1.05; M Wt: 14659.976; M formula: C624H986N197O204S1, mol ex coeff: 10020.Activity: inhibited the growth of P. aeruginosa PAO1 at 17 uM (250 ug/ml) but not other bacteria tested.Structure:  Alphafold2 predicted several beta strands. Model in the paper to be confirmed.Recombinant production:bacteria:Escherichia coli: IPTG-induced, His-tag form expressed in strain BL21(DE3) as insoluble fraction. It may form multimers even under reducing conditions.",
            "Similar Sequences": []
        }
    }
}